New drug duo aims to shrink oral cancers before surgery
NCT ID NCT07545083
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving two drugs together before surgery can shrink advanced mouth or throat cancers. The drugs are becotatug vedotin and pucotenlimab. About 26 people with stage III or IVa cancer will take part. The goal is to see if the cancer nearly or completely disappears in the removed tissue.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED ORAL AND OROPHARYNGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New study tests best Follow-Up after surgery for oral cancer
- New combo therapy aims to stop oral cancer from coming back
- New combo therapy offers hope for head and neck cancer patients unable to take standard chemo
- New drug combo aims to boost chemoradiation for head and neck cancer
- Mouth bacteria may predict cancer treatment success